Drugs to promote sinus rhythm reversion and maintenance in atrial fibrillation - Why amiodarone is better

Cardiovascular Drugs and Therapy

Volumn 17, Issue 1, 2003, Pages 5-6

  Nattel, Stanley ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; DILTIAZEM; VERAPAMIL;

CARDIOVERSION; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; ELECTRICAL REMODELING; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE REMODELING; HUMAN; PRIORITY JOURNAL; RECURRENCE RISK; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; ELECTRIC COUNTERSHOCK; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0042347824     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024295422944     Document Type: Editorial

References (12)

1. Manios EG, Mavrakis HE, Kanoupakis EM, et al. Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates. A randomized controlled study. Cardiovascular Drugs and Therapy 17(1):31-40.
2. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
3. Yue L, Feng J, Gaspo R, Li G-R, Wang Z, Nattel S. Ionic remodelling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 1997;81:512-525.
4. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94:2968-2974.
5. Tieleman RG, De Langen CDJ, Van Gelder IC, et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 1997;95:1945-1953.
6. Lee SH, Yu WC, Cheng JJ, et al. Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling. Circulation 2000;101:200-206.
7. Fareh S, Benardeau A, Nattel S. Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs. Cardiovasc Res 2001;49:762-770.
8. De Simone A, Stabile G, Vitale DF, et al. Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol 1999;34:810-814.
9. Van Noord T, Van Gelder IC, Tieleman RG, et al. VERDICT: The verapamil versus digoxin cardioversion trial: A randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2001;12:766-769.
10. Bertaglia E, D'este D, Zanocco A, et al. Effects of pretreatment with verapamil on early recurrences after electrical cardioversion of persistent atrial fibrillation: A randomised study. Heart 2001;85:578-580.
11. Bosch RF, Li GR, Gaspo R, Nattel S. Electrophysiologic effects of chronic amiodarone therapy and hypothyroidism, alone and in combination, on guinea pig ventricular myocytes. J Pharm Exp Therap 1999;289:156-165.
12. Shinagawa K, Shiroshita-Takeshita A, Schram G, Nattel S. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: Insights into the mechanism of amiodarone's superior efficacy. Circulation 2003;107:1440-1446.